Insider Trading? Huge Bet Made Shortly Before STAT News Report Touting Gilead's Remdesivir ResultsChris MenahanInformationLiberation Apr. 20, 2020 |
Mike Johnson Pushes Debunked Lie That Israeli Babies Were 'Cooked in Ovens' On October 7
'Sniper Seen on Roof Overlooking Pro-Palestine Protest' at Indiana University
'It Has to Be Stopped': Netanyahu Demands Pro-Palestine Protests at U.S. Colleges Be Shut Down
'These Protesters Belong in Jail': Gov. Abbott Cheers Arrest of Pro-Palestine Protesters at UT Austin
Claim Jewish Student Was 'Stabbed In The Eye' by Pro-Palestine Protester Draws Mockery After Video Released
STAT News writer Adam Fuerstein's market-moving article on Thursday touting leaked early trial results for Gilead's drug Remdesivir is raising suspicions and has one congressman calling for a Securities and Exchange Commission investigation. Trader Tian Zeng on Thursday night highlighted a suspiciously timed large bet that Gilead's stock would surge within around 24 hours:
The mystery investor appears to have made a killing.
From CNN, "Congressman calls for SEC investigation into leak about possible coronavirus drug": A congressman on Friday called for the Securities and Exchange Commission to investigate the leak of a video showing physicians at the University of Chicago speaking enthusiastically about an experimental drug to treat Covid-19.CNBC's Jim Cramer on Thursday touted Feuerstein as "the best there is and a great friend" and praised his article:
On Friday, CNBC also had Feuerstein on the air: As I reported Friday, the media hyped this report massively with little skepticism -- despite being hyper-skeptical of hydroxychloroquine and relentlessly bashing Trump for touting it. As Rep. Doggett said, this demands a thorough SEC investigation.
Follow InformationLiberation on Twitter, Facebook, Gab and Minds. |